Publicaciones en colaboración con investigadores/as de Hospital Universitario Arnau de Vilanova (29)

2024

  1. Sprouty1 is a broad mediator of cellular senescence

    Cell Death and Disease, Vol. 15, Núm. 4

2023

  1. Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness

    Molecular Oncology, Vol. 17, Núm. 1, pp. 98-118

  2. PKN1 Kinase: A Key Player in Adipocyte Differentiation and Glucose Metabolism

    Nutrients, Vol. 15, Núm. 10

2022

  1. Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

    Cancers, Vol. 14, Núm. 12

2019

  1. Sympathetic Hyperactivity and Sleep Disorders in Individuals With Type 2 Diabetes

    Frontiers in Endocrinology, Vol. 10

2017

  1. Endometrial carcinoma: Specific targeted pathways

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 149-207

2016

  1. 2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels

    Pigment Cell and Melanoma Research, Vol. 29, Núm. 3, pp. 352-371

  2. Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer

    Molecular Imaging and Biology, Vol. 18, Núm. 4, pp. 545-556

  3. Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism

    Oncotarget, Vol. 7, Núm. 32, pp. 52364-52374

2013

  1. Endometrial carcinoma: Molecular alterations involved in tumor development and progression

    Oncogene, Vol. 32, Núm. 4, pp. 403-413

2012

  1. Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells

    Molecular Oncology, Vol. 6, Núm. 5, pp. 530-541

  2. Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: Role for proteins involved in resistance to apoptosis and hypoxia

    Histopathology, Vol. 60, Núm. 3, pp. 460-471

  3. Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway

    International Journal of Cancer, Vol. 130, Núm. 4, pp. 967-978

  4. New therapeutic targets in melanoma

    Actas Dermo-Sifiliograficas, Vol. 103, Núm. 7, pp. 579-590

2011

  1. KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels

    American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543

  2. Nuclear factor-B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner

    Laboratory Investigation, Vol. 91, Núm. 6, pp. 859-871

  3. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma

    Human Pathology, Vol. 42, Núm. 2, pp. 185-193

2010

  1. A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis

    American Journal of Pathology, Vol. 176, Núm. 6, pp. 2722-2731

  2. The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms

    European Journal of Cancer, Vol. 46, Núm. 4, pp. 836-850

2009

  1. A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma

    Analytical and Quantitative Cytology and Histology, Vol. 31, Núm. 4, pp. 217-226